Skip to content

Clinical trials

Hepatitis C, Chronic trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C, Chronic Country / region: Brazil Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20042
20051
20075
20083
20092
20105
20113
20124
20141
20151
20181
20191
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche16
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)3
Federal University of São Paulo2
GlaxoSmithKline2
AbbVie1
Atea Pharmaceuticals, Inc.1
Boehringer Ingelheim1
Hospital de Clinicas de Porto Alegre1
Human Genome Sciences Inc.1
Janssen Infectious Diseases BVBA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C, Chronic32
Hepatitis C9
Hepatitis2
Fibrosis1
Flaviviridae Infections1
Liver Cirrhosis1
Persistent Infection1
RNA Virus Infections1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.